Iprozilamine
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171841This classification denotes an antiemetic agent with the molecular formula C13H22ClN5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8WTG4RSP9Y, chemically known as pyrimidine, 4-chloro-2-isopropylamino-6-(4-methylpiperazino)-5-methylthio- but generally known as iprozilamine, which bears US NIH Compound Identifier 68725. European Medicines Agency schedules Iprozilamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08288MIG. The term IPROZILAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). IPROZILAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iprozilamine under HS 29335995 and SITC 51576. As of Q4 2014, IPROZILAMINE remains the US FDA Preferred Term for this commodity. Iprozilamine bears US NLM identifiers UMLS ID C1881265 and NCI Concept Code C65958. SMILES: CLC1NC(NC(N2CCN(CC2)C)C1SC)NC(C)C.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.